Bicycle Therapeutics (BCYC) Operating Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3,724.00 |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - | -667,875.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -667,875.00 |
| Dec 31, 2025 | 177,326.00 |
| Sep 30, 2025 | 182,723.00 |
| Jun 30, 2025 | -246,751.00 |
| Mar 31, 2025 | -39,870.00 |
| Dec 31, 2024 | -80,743.00 |
| Sep 30, 2024 | -143,675.00 |
| Jun 30, 2024 | -12,005.00 |
| Mar 31, 2024 | 54,886.00 |
| Dec 31, 2023 | -63,389.00 |
| Sep 30, 2023 | 2,979.00 |
| Jun 30, 2023 | -5,327.00 |
| Mar 31, 2023 | -14,442.00 |
| Dec 31, 2022 | 74,304.00 |
| Sep 30, 2022 | -64,903.00 |
| Jun 30, 2022 | 64,290.00 |
| Mar 31, 2022 | 17,688.00 |
| Dec 31, 2021 | -68,315.00 |
| Sep 30, 2021 | -5,204.00 |
| Jun 30, 2021 | -16,694.00 |
| Mar 31, 2021 | 14,498.00 |
| Dec 31, 2020 | -35,314.00 |
| Sep 30, 2020 | 139,202.00 |
| Jun 30, 2020 | -27,612.00 |
| Mar 31, 2020 | -97,967.00 |
| Dec 31, 2019 | 62,332.00 |
| Sep 30, 2019 | -127,502.00 |
| Jun 30, 2019 | -22,634.00 |